| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.17 | 0.0008 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0008 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.001 |